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In today’s modern society, aided by the fast development of re-
combinant DNA technology, large amounts of biotech-based 
products that are generated by microbial cell factories provide 
important substances to the traditional food, pharmaceutical 
and chemistry industries. For instance, enzymes, including pro-
teases, amylases, and lipases, serve as eﬃ  cient product addi-
tives in detergents and as catalysts in biofuel industry [1]. In 
Europe alone, the proteases, which are commonly used in the 
detergent industry, account for 900 tons of pure enzymes per 
year [1]. The global market for industrial proteins is growing 
rapidly, and therefore, the development of highly eﬃ  cient pro-
duction systems is in high demand. Bacillus subtilis is widely 
applied as a microbial cell factory, due to the fact that achiev-
ing large-scale production at high cell densities is relatively 
straightforward and inexpensive [2]. Moreover, its high genetic 
accessibility and amenability provide excellent possibilities for 
further modiﬁ cation by molecular genetic techniques [3]. Most 
importantly, this microbial host that is generally recognized as 
safe (GRAS), can naturally secrete high amounts of products (up 
to 20–25 gram per liter) directly into fermentation media [4]. 
Thus, this production host is highly favored over other famous 
production organisms such as Escherichia coli in view of the 
relatively simple downstream puriﬁ cation processing. There-
fore, B. subtilis and its close relatives that can deliver higher 
yields of industrial enzymes at lower costs, have become of sub-
stantial economic importance.
B. subtilis, has been subjected to extensive exploitation for 
protein production during approximately three decades, which 
was initiated by the overexpression of proteins derived from 
Bacillus species. The high-level production of more complex 
proteins or enzymes that originate from Gram-negative bacte-
ria or humans was severely hampered [2]. Numerous attempts, 
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mutagenize), regional optimization of speciﬁ c pathways, have 
been tried to achieve the overproduction of heterologous pro-
teins in this cell factory [5]. However, these strain modiﬁ cation 
approaches have already more or less touched the ceiling, and 
commonly, one speciﬁ c protein improvement method cannot 
ensure high-level production of other proteins [6]. To increase 
the production capacity and also broaden the range of proteins 
that can be overexpressed in B. subtilis, more knowledge about 
the cellular process and the development of better production 
systems is still highly needed. Throughout this whole thesis, we 
further explored the production potential of B. subtilis for both 
secretory and intracellular proteins as well as investigated the 
underlying reasons, for which both traditional approaches and 
novel genetic engineering and analytical tools were used.   
In Chapter 2, we investigated the B. subtilis cell surface com-
position regarding its protein secretion capacity of recombinant 
α-amylase variants with either low-, neutral- or high- isoelec-
tric points (pI). The protein secretion mechanism is increasingly 
clear. As shown in Fig. 1, pre-protein needs to successively go 
through the cell membrane lipid bilayer and cell wall, and then 
be excreted into the media by Sec-type secretion; another sys-
tem for secretion, but speciﬁ cally for folded proteins is the Tat 
system (not further shown and discussed here). During the 
Sec-secretion process, the secreted target is modiﬁ ed to be a 
mature protein by interacting with cell surface components 
and embedded quality-control proteases. We demonstrate that 
the absence of the cell membrane phospholipid biosynthesis-re-
lated enzymes PssA and/or ClsA are beneﬁ cial for various α-am-
ylases secretion yields. Although a full understanding of the in-
teraction between the secreted protein and the membrane lipid 
bilayer is still incomplete, the improved secretion ability shows 
high correlation with the presence of overall anionic phospho-













expression hosts. In this study, a combinatorial strain improve-
ment strategy, which consists of codon optimization, tunable 
expression system, speciﬁ c modiﬁ cation of the secretion ma-
chinery (cell envelope engineering in this case), was employed 
for improving the secretion eﬃ  ciency of protein candidates. 
Here, we speciﬁ cally studied two variables, that is, cell enve-
lope components and the pIs of secreted proteins. A variety of 
other relevant factors that also play vital roles in the secretion 
of end-products, such as signal peptides, translocases, were out 
of the scope of this study. So, it is foreseeable that, on the basis 
of the previously engineered strains, huge enhancement of the 
product yields might be achieved by integrating more eﬃ  cient 
modiﬁ cations of secretion-limiting factors.
In the past twenty years, most of the metabolic optimization 
methods have focused on the engineering of regional pathways 
or speciﬁ c steps, while a novel strategy directed on transcription 
Fig. 1. Schematic representation of the Sec-dependent secretion pathway 
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regulation that can achieve multiple and simultaneous modiﬁ -
cations, has rarely been applied. In Chapter 3, the global tran-
scription machinery engineering (gTME) approach was utilized 
to unlock phenotypes in overexpressing a target protein by 
Fig. 2. Workﬂ ow of the black-white selection for β-galactosidase high-
er-producing phenotypes. Desired phenotypes (dark colonies, the substrate 
S-gal can be degraded by β-galactosidase into black products) were selected. 
Next, all the collected colonies were subjected to a second screening round, 














randomly mutagenizing the pleiotropic transcriptional regula-
tors CodY and CcpA. In combination with black-white selection, 
we eﬃ  ciently isolated variants with enhanced production of 
the reporter protein β-galactosidase (Fig. 2). The best mutant 
contained two amino acid substitutions within the DNA-bind-
ing HTH domains, CodYR214C and CcpAT19S, and increased the pro-
duction level of β-galactosidase up to 290% relative to the wild-
type control. This well-designed toolkit that expands the scale 
of pathway modiﬁ cation to a global level, can remarkably and 
straightforwardly lead to strain enhancement, even without 
the complete understanding of the metabolic networks [7, 8]. 
Besides the initially used β-galactosidase, some other recom-
binant proteins, including GFP, xylanase, and peptidase, were 
also signiﬁ cantly higher-produced in the selected cell factory 
CodYR214CCcpAT19S. Since the overexpression of different proteins 
probably has varying utilization biases for available intracellu-
lar nutrient sources, the effect of the strain improvement dif-
fers per protein used. Notwithstanding, our best engineered 
microbial host obtained from gTME libraries still obviously 
broadens the application in overproducing a wide range of pro-
teins. Although the direct deletion of CodY and/or CcpA can al-
ready improve the production of β-galactosidase by 10–30%, we 
still utilized the relatively complex gTME-based approach, not 
only for overexpressing the target protein even more, but also 
to further study the interesting mutants, uncovering hidden in-
formation behind the rewired metabolic networks.
In Chapter 4, we analyzed the transcriptome perturba-
tions at a global level in the previously obtained expression 
host CodYR214CCcpAT19S by using RNA-sequencing. Moreover, 
DNA-protein binding analysis of the two mutated regulatory 
proteins was performed by gel electrophoretic mobility shift 
assays (EMSA). As demonstrated in Fig. 3, CcpA can indirectly 












regulation that can achieve multiple and simultaneous modiﬁ -
cations, has rarely been applied. In Chapter 3, the global tran-
scription machinery engineering (gTME) approach was utilized 
to unlock phenotypes in overexpressing a target protein by 
Fig. 2. Workﬂ ow of the black-white selection for β-galactosidase high-
er-producing phenotypes. Desired phenotypes (dark colonies, the substrate 
S-gal can be degraded by β-galactosidase into black products) were selected. 
Next, all the collected colonies were subjected to a second screening round, 














randomly mutagenizing the pleiotropic transcriptional regula-
tors CodY and CcpA. In combination with black-white selection, 
we eﬃ  ciently isolated variants with enhanced production of 
the reporter protein β-galactosidase (Fig. 2). The best mutant 
contained two amino acid substitutions within the DNA-bind-
ing HTH domains, CodYR214C and CcpAT19S, and increased the pro-
duction level of β-galactosidase up to 290% relative to the wild-
type control. This well-designed toolkit that expands the scale 
of pathway modiﬁ cation to a global level, can remarkably and 
straightforwardly lead to strain enhancement, even without 
the complete understanding of the metabolic networks [7, 8]. 
Besides the initially used β-galactosidase, some other recom-
binant proteins, including GFP, xylanase, and peptidase, were 
also signiﬁ cantly higher-produced in the selected cell factory 
CodYR214CCcpAT19S. Since the overexpression of different proteins 
probably has varying utilization biases for available intracellu-
lar nutrient sources, the effect of the strain improvement dif-
fers per protein used. Notwithstanding, our best engineered 
microbial host obtained from gTME libraries still obviously 
broadens the application in overproducing a wide range of pro-
teins. Although the direct deletion of CodY and/or CcpA can al-
ready improve the production of β-galactosidase by 10–30%, we 
still utilized the relatively complex gTME-based approach, not 
only for overexpressing the target protein even more, but also 
to further study the interesting mutants, uncovering hidden in-
formation behind the rewired metabolic networks.
In Chapter 4, we analyzed the transcriptome perturba-
tions at a global level in the previously obtained expression 
host CodYR214CCcpAT19S by using RNA-sequencing. Moreover, 
DNA-protein binding analysis of the two mutated regulatory 
proteins was performed by gel electrophoretic mobility shift 
assays (EMSA). As demonstrated in Fig. 3, CcpA can indirectly 












of the intracellular BCAA pool [9, 10]. Thus, the expression pat-
terns of these two regulators were exactly opposite to each other 
in various mutants. In addition, the amino acid substitutions 
within the HTH domains of the two transcription factors al-
tered the overall binding speciﬁ city to their direct target genes. 
In effect, the carbon metabolism was further repressed, while 
the nitrogen metabolism was obviously de-repressed, which in 
conjunction resulted in a system-wide metabolic shift allowing 
for enhanced synthesis capacity of the target protein. Moreover, 
only a small portion of regulated genes exhibited signiﬁ cant re-
sponses to the transcriptome perturbations, reﬂ ecting that the 
vast majority of genes are under control of complex, multiple 
forms of expression regulation, which probably meet the needs 
of maintaining the cellular processes at a relatively steady state 
[11]. The carbon core metabolism, which has been well-evolved 
to guarantee essential energy and building block supply in the 
cell [12], is less responsive to the transcriptional regulatory al-
terations. In comparison, there is still space to further adjust 
the nitrogen metabolic networks for the overproduction of het-
erologous recombinant proteins that has been demonstrated in 
Chapter 3. Furthermore, solid relevant evidence can be possi-
bly achieved by further analyzing the metabolic ﬂ ux and im-
plementing glucose or amino acid consumption assays of the 
obtained mutants. Taken together, we speculate that the reor-
ganization of cellular metabolic ﬂ uxes reduces the metabolic 
burden by allowing a better balance of resource distributions 
for both essential native metabolic networks and heterologous 
protein overproduction pathways. 
Under nutrient-limiting growth conditions, B. subtilis cells 
activate a variety of regulatory processes to determine diverse 
cell fates, such as sporulation, competence development, bio-
ﬁ lm formation, and differentiate into a community of multi-













heterogeneity [13]. In the study of heterologous protein produc-
tion in cell factories, major research efforts have focused on 
the product yield at the population level, while the production 
activity of individual cells has largely been ignored. A recent 
study demonstrated that the production of amylases in B. subti-
lis is performed in a non-uniform manner, and a degU mutation 
and optimized growth conditions can signiﬁ cantly improve the 
overall secretion yields by suppressing the heterogeneity in ex-
pression [4]. In Chapter 3, we presented that the well-known 
reporter protein GFP, which is mostly used as a benchmark for 
visualizing protein localization and promoter activity, can be 
higher-expressed in the best β-gal producer CodYR214CCcpAT19S. In 
Chapter 5, we demonstrate that the ﬂ uorescence signals of GFP 
are dynamic over time and differ in strains with various global 
regulator mutation backgrounds. Strains harboring CodYR214C 
showed a high similarity in growth curve and GFP expression 
performance at the population, subpopulation and single-cell 
levels. In comparison to the expression hosts carrying wild-
type versions of CodY, the CodYR214C-containing strains, although 
showing slightly lower growth rates, had overall higher GFP 
product yields. We initially regarded this difference as a con-
sequence of the relatively different growth rate, but the follow-
ing analyses at the single-cell and subpopulation levels showed 
high consistency of the overall protein yield with the homogene-
ity of high-expressing populations. In other words, the expres-
sion heterogeneity, which can be regarded as phenotypic noise, 
comes from global regulation, suggesting a negative correlation 
with overall GFP production in the cell factories we assessed, 
especially during the late stationary growth phase. We reason 
that the strains with CodYR214C have reprogrammed metabolic 
networks that focus more on the target protein synthesis, while 
in the wild-type with an imbalanced metabolic ﬂ ux distribution, 












of the intracellular BCAA pool [9, 10]. Thus, the expression pat-
terns of these two regulators were exactly opposite to each other 
in various mutants. In addition, the amino acid substitutions 
within the HTH domains of the two transcription factors al-
tered the overall binding speciﬁ city to their direct target genes. 
In effect, the carbon metabolism was further repressed, while 
the nitrogen metabolism was obviously de-repressed, which in 
conjunction resulted in a system-wide metabolic shift allowing 
for enhanced synthesis capacity of the target protein. Moreover, 
only a small portion of regulated genes exhibited signiﬁ cant re-
sponses to the transcriptome perturbations, reﬂ ecting that the 
vast majority of genes are under control of complex, multiple 
forms of expression regulation, which probably meet the needs 
of maintaining the cellular processes at a relatively steady state 
[11]. The carbon core metabolism, which has been well-evolved 
to guarantee essential energy and building block supply in the 
cell [12], is less responsive to the transcriptional regulatory al-
terations. In comparison, there is still space to further adjust 
the nitrogen metabolic networks for the overproduction of het-
erologous recombinant proteins that has been demonstrated in 
Chapter 3. Furthermore, solid relevant evidence can be possi-
bly achieved by further analyzing the metabolic ﬂ ux and im-
plementing glucose or amino acid consumption assays of the 
obtained mutants. Taken together, we speculate that the reor-
ganization of cellular metabolic ﬂ uxes reduces the metabolic 
burden by allowing a better balance of resource distributions 
for both essential native metabolic networks and heterologous 
protein overproduction pathways. 
Under nutrient-limiting growth conditions, B. subtilis cells 
activate a variety of regulatory processes to determine diverse 
cell fates, such as sporulation, competence development, bio-
ﬁ lm formation, and differentiate into a community of multi-













heterogeneity [13]. In the study of heterologous protein produc-
tion in cell factories, major research efforts have focused on 
the product yield at the population level, while the production 
activity of individual cells has largely been ignored. A recent 
study demonstrated that the production of amylases in B. subti-
lis is performed in a non-uniform manner, and a degU mutation 
and optimized growth conditions can signiﬁ cantly improve the 
overall secretion yields by suppressing the heterogeneity in ex-
pression [4]. In Chapter 3, we presented that the well-known 
reporter protein GFP, which is mostly used as a benchmark for 
visualizing protein localization and promoter activity, can be 
higher-expressed in the best β-gal producer CodYR214CCcpAT19S. In 
Chapter 5, we demonstrate that the ﬂ uorescence signals of GFP 
are dynamic over time and differ in strains with various global 
regulator mutation backgrounds. Strains harboring CodYR214C 
showed a high similarity in growth curve and GFP expression 
performance at the population, subpopulation and single-cell 
levels. In comparison to the expression hosts carrying wild-
type versions of CodY, the CodYR214C-containing strains, although 
showing slightly lower growth rates, had overall higher GFP 
product yields. We initially regarded this difference as a con-
sequence of the relatively different growth rate, but the follow-
ing analyses at the single-cell and subpopulation levels showed 
high consistency of the overall protein yield with the homogene-
ity of high-expressing populations. In other words, the expres-
sion heterogeneity, which can be regarded as phenotypic noise, 
comes from global regulation, suggesting a negative correlation 
with overall GFP production in the cell factories we assessed, 
especially during the late stationary growth phase. We reason 
that the strains with CodYR214C have reprogrammed metabolic 
networks that focus more on the target protein synthesis, while 
in the wild-type with an imbalanced metabolic ﬂ ux distribution, 





























































































































































































































GFP expression pathway. This can be considered as a popula-
tion-scale survival strategy for the wild-type strain under sub-
optimal nutrient conditions by ensuring a small proportion of 
high-producing cells and another low-producing subpopulation 
as cost. Although the detailed mechanism underlying the GFP 
expression heterogeneity is still incomplete, this study offers a 
new perspective into the overexpression of recombinant pro-
teins and paves the way to further increase the use of  B. subtilis 
as a cell factory. 
OUTLOOK
In natural environments, wild-type bacterial cells have evolved 
sophisticated adaptation systems that allow them to take ad-
vantage of many kinds of nutrient sources for optimal ﬁ tness 
during changing nutritional conditions [14]. With their intricate 
regulatory systems, the bacteria know where they are by sens-
ing the availability level of metabolites, and then stimulate the 
global metabolic regulation and motility mechanisms for shift-
ing to the place they should be as a response [14]. However, the 
human-imposed task for overexpressing proteins of industrial 
and commercial interest, especially the heterologous ones, has 
not been evolved over time spent in nature. Therefore, modify-
ing the global regulatory networks in the existing cell factories 
like B. subtilis to obtain a better expression host appears to be a 
good solution. We are now able to unlock a comprehensive pro-
ﬁ le inside the cells by use of ‘omics’ technologies, and numer-
ous systematic functional studies have considerably enhanced 
our understanding of the complex metabolic and regulatory 
pathways in B. subtilis [15–18]. Moreover, the newly developed 
systems and synthetic biology devices, such as CRISPR-Cas9 
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possibilities that potentially facilitate strain improvements 
[19, 20]. Undoubtedly, we are still at the early stages of devel-
oping B. subtilis as a highly adaptable chassis with both higher 
yields and a wider range of products. Nevertheless, novel in-
sights into the complicated cellular and global regulatory pro-
cesses and the great advances in technological tools will lead to 
the construction of super-producing cell factories.  
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Bacillus subtilis global regulatory protein CodY. Proc Natl Acad Sci U S A. 
2014;111:8227–8232.
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possibilities that potentially facilitate strain improvements 
[19, 20]. Undoubtedly, we are still at the early stages of devel-
oping B. subtilis as a highly adaptable chassis with both higher 
yields and a wider range of products. Nevertheless, novel in-
sights into the complicated cellular and global regulatory pro-
cesses and the great advances in technological tools will lead to 
the construction of super-producing cell factories.  
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